SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (14601)2/11/1998 12:04:00 PM
From: Andrew H  Respond to of 32384
 
Perhaps one can judge the future strength of a stock by the current stupidity of those who trash it? (:>)

Actually, the Panretin news is very, very good. The best part is that the drug gets more effective the longer it is used. We may still not know where that effect stops. Of course the longer it is used, the longer people will need to take it. If it can be used instead of or as an adjunct to chemotherapy, its prospects are very bight.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News